At LenioBio, we develop efficient, robust and sustainable technologies to disrupt the way medicines and food are produced for those in need, wherever they are. Unconstrained by the limitations of cells, we combine our proprietary protein technology with machine learning to significantly accelerate innovation cycles in life science industry.
19 June 2024, Little Rock AR Little Rock, AR — In a strategic move set to redefine the landscape of protein production across North America, LenioBio GmbH, a life sciences biotech company pioneering disruptive protein expression technologies, and leading life sciences marketplace, Labscoop LLC, announce a strategic partnership to bring LenioBio’s line of cutting-edge products and services to Labscoop Marketplace users and the North American market more broadly.